![Paul Varley, PhD](/images/librariesprovider24/home/24/paul_varley.png?sfvrsn=baa9b1b7_2)
What Have Monoclonal Antibodies Ever Done for Us? Past, Present and Future Perspectives on Antibodies and How They Have Driven Bioprocessing Progress
Paul Varley, PhD
SVP, Development, Alchemab Therapeutics
![Eva Rohde, M.D.](/images/librariesprovider24/home/24/eva_rohde.png?sfvrsn=82d1dfa7_1)
Extracellular Vesicles as Promising Drug Modalities in Spinal Cord Injury and Other (Neuro-)Degenerative Diseases
Eva Rohde, M.D.
Chair, Transfusion Medicine, Director GMP Unit, Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University Salzburg